BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16242830)

  • 1. Influence of a low-molecular-weight heparin derivative on the nitric oxide levels and apoptotic DNA damage in adriamycin-induced cardiac and renal toxicity.
    Deepa PR; Varalakshmi P
    Toxicology; 2006 Jan; 217(2-3):176-83. PubMed ID: 16242830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical evaluation of the inflammatory changes in cardiac, hepatic and renal tissues of adriamycin-administered rats and the modulatory role of exogenous heparin-derivative treatment.
    Deepa PR; Varalakshmi P
    Chem Biol Interact; 2005 Oct; 156(2-3):93-100. PubMed ID: 16154121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial cardio-renovascular effects of a low-molecular-weight heparin-derivative on adriamycin-induced glycosaminoglycanuria and tissue lipid abnormalities.
    Deepa PR; Varalakshmi P
    Toxicology; 2005 Jul; 211(1-2):77-85. PubMed ID: 15863250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Favourable modulation of the inflammatory changes in hypercholesterolemic atherogenesis by a low-molecular-weight heparin derivative.
    Deepa PR; Varalakshmi P
    Int J Cardiol; 2006 Jan; 106(3):338-47. PubMed ID: 16337042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of low molecular weight heparin on oxidative injury and cellular abnormalities in adriamycin-induced cardiac and hepatic toxicity.
    Deepa PR; Varalakshmi P
    Chem Biol Interact; 2003 Oct; 146(2):201-10. PubMed ID: 14597133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity.
    Yilmaz S; Atessahin A; Sahna E; Karahan I; Ozer S
    Toxicology; 2006 Feb; 218(2-3):164-71. PubMed ID: 16325981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atheroprotective effect of exogenous heparin-derivative treatment on the aortic disturbances and lipoprotein oxidation in hypercholesterolemic diet fed rats.
    Deepa PR; Varalakshmi P
    Clin Chim Acta; 2005 May; 355(1-2):119-30. PubMed ID: 15820486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of doxorubicin-induced cardiac and renal toxicity by pirfenidone in rats.
    Giri SN; Al-Bayati MA; Du X; Schelegle E; Mohr FC; Margolin SB
    Cancer Chemother Pharmacol; 2004 Feb; 53(2):141-50. PubMed ID: 14564477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low molecular weight heparin suppresses tumor necrosis factor expression from deep vein thrombosis.
    Carr JA; Cho JS
    Ann Vasc Surg; 2007 Jan; 21(1):50-5. PubMed ID: 17349336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low molecular weight heparin protection against oxalate-induced oxidative renal insult.
    Rajeswari A; Varalakshmi P
    Clin Chim Acta; 2006 Aug; 370(1-2):108-14. PubMed ID: 16516183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats.
    El-Shitany NA; El-Haggar S; El-desoky K
    Food Chem Toxicol; 2008 Jul; 46(7):2422-8. PubMed ID: 18487002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salubrious effects of lipoic acid against adriamycin-induced clastogenesis and apoptosis in Wistar rat bone marrow cells.
    Prahalathan C; Selvakumar E; Varalakshmi P; Kumarasamy P; Saravanan R
    Toxicology; 2006 May; 222(3):225-32. PubMed ID: 16580770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo protection of dna damage associated apoptotic and necrotic cell deaths during acetaminophen-induced nephrotoxicity, amiodarone-induced lung toxicity and doxorubicin-induced cardiotoxicity by a novel IH636 grape seed proanthocyanidin extract.
    Ray SD; Patel D; Wong V; Bagchi D
    Res Commun Mol Pathol Pharmacol; 2000; 107(1-2):137-66. PubMed ID: 11334364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adriamycin-induced, TNF-alpha-mediated central nervous system toxicity.
    Tangpong J; Cole MP; Sultana R; Joshi G; Estus S; Vore M; St Clair W; Ratanachaiyavong S; St Clair DK; Butterfield DA
    Neurobiol Dis; 2006 Jul; 23(1):127-39. PubMed ID: 16697651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cytoprotective role of a low-molecular-weight heparin fragment studied in an experimental model of glomerulotoxicity.
    Deepa PR; Varalakshmi P
    Eur J Pharmacol; 2003 Oct; 478(2-3):199-205. PubMed ID: 14575805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favourable influence of low molecular weight heparin in mitigating the peroxidative membrane damage induced by a cytotoxic agent and an atherogenic diet.
    Deepa PR; Varalakshmi P
    Hum Exp Toxicol; 2003 May; 22(5):229-35. PubMed ID: 12774884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of low molecular weight heparin on pancreatic micro-circulation in severe acute pancreatitis in a rodent model.
    Qiu F; Lü XS; Huang YK
    Chin Med J (Engl); 2007 Dec; 120(24):2260-3. PubMed ID: 18167214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium nitroprusside and L-arginine attenuates ferric nitrilotriacetate-induced oxidative renal injury in rats.
    Gupta A; Chander V; Sharma S; Chopra K
    Toxicology; 2007 Apr; 232(3):183-91. PubMed ID: 17280760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo Comet assay on isolated kidney cells to distinguish genotoxic carcinogens from epigenetic carcinogens or cytotoxic compounds.
    Nesslany F; Zennouche N; Simar-Meintières S; Talahari I; Nkili-Mboui EN; Marzin D
    Mutat Res; 2007 Jun; 630(1-2):28-41. PubMed ID: 17507283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic rats treated by low molecular weight heparin OP 2123/parnaparin: morphological changes in the kidney and heart.
    Artico M; De Santis S; Tranquilli Leali FM; Cavallotti D; Celestini A; Cavallotti C
    J Diabetes Complications; 2004; 18(2):119-25. PubMed ID: 15120707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.